Stock Price
2.15
Daily Change
0.05 2.14%
Monthly
-14.00%
Yearly
25.73%
Q4 Forecast
2.53


Peers Price Chg Day Year Date
Avita Medical 3.93 -0.04 -1.01% 18.37% Nov/22
Aurora Cannabis 6.05 0.03 0.50% -3.97% Nov/22
Acasti Pharma 3.28 0.05 1.55% 55.10% Nov/22
Tectonic Therapeutic 48.10 3.21 7.15% 217.99% Nov/22
Cronos Group 2.90 0.06 2.11% 6.23% Nov/22
Knight Therapeutics 5.29 -0.01 -0.19% 0.57% Nov/22
Ionis Pharmaceuticals 34.01 0.07 0.21% -31.75% Nov/22
IQVIA Holdings 197.93 0.54 0.27% -6.64% Nov/22
Dianthus Therapeutics 22.34 2.07 10.21% 90.94% Nov/22
Moderna 41.14 2.82 7.35% -47.61% Nov/22
Organigram Holdings 2.15 0.05 2.14% 25.73% Nov/22
Organon & Co 15.28 0.39 2.59% 34.46% Nov/22
Revvity 112.26 1.13 1.02% 24.61% Nov/22
Tilray 1.88 0.04 2.17% -22.63% Nov/22
Viatris 13.40 0.16 1.17% 42.05% Nov/22
Canopy Growth 5.48 0.07 1.29% -29.74% Nov/22
Xeris Pharmaceuticals 3.09 0.05 1.64% 60.10% Nov/22
Alaunos Therapeutics 2.39 0.07 3.02% -76.10% Nov/22

Indexes Price Day Year Date
TSX 25444 53.60 0.21% 26.48% Nov/22

Organigram Holdings Inc traded at 2.15 this Friday November 22nd, increasing 0.05 or 2.14 percent since the previous trading session. Looking back, over the last four weeks, Organigram Holdings gained 14.00 percent. Over the last 12 months, its price rose by 25.73 percent. Looking ahead, we forecast Organigram Holdings Inc to be priced at 2.53 by the end of this quarter and at 2.45 in one year, according to Trading Economics global macro models projections and analysts expectations.